{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:14:50Z","timestamp":1778901290208,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"am","delay-in-days":263,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K01AR073923"],"award-info":[{"award-number":["K01AR073923"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bone.2021.116201","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T12:13:17Z","timestamp":1631794397000},"page":"116201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice"],"prefix":"10.1016","volume":"154","author":[{"given":"Kelsey A.","family":"Carpenter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reid","family":"Davison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Shakthivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle D.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank C.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan D.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116201_bb0005","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"342","article-title":"Hypophosphatemic vitamin D-resistant rickets","volume":"Vol. 6th Ed","author":"Alon","year":"2006"},{"issue":"2","key":"10.1016\/j.bone.2021.116201_bb0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium","volume":"11","year":"1995","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.116201_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00590-014-1496-y","article-title":"Hypophosphatemic rickets: etiology, clinical features and treatment","volume":"25","author":"Pavone","year":"2015","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"issue":"1","key":"10.1016\/j.bone.2021.116201_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.bone.2021.116201_bb0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2021.116201_bb0030","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician\u2019s guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bone.2021.116201_bb0035","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bone.2021.116201_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1\u03b1-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2021.116201_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00223-017-0333-9","article-title":"Fibroblast growth factor (FGF) 23 regulates the plasma levels of parathyroid hormone in vivo through the FGF receptor in normocalcemia, but not in hypocalcemia","volume":"102","author":"Mace","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"7","key":"10.1016\/j.bone.2021.116201_bb0050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jbmr.3992","article-title":"Hyperparathyroidism in patients with X-linked hypophosphatemia","volume":"35","author":"Lecoq","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116201_bb0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jbmr.3923","article-title":"Sclerostin antibody treatment increases bone mass and normalizes circulating phosphate levels in growing Hyp mice","volume":"35","author":"Carpenter","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"15","key":"10.1016\/j.bone.2021.116201_bb0060","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc.Natl.Acad.Sci.U.S.A"},{"issue":"1","key":"10.1016\/j.bone.2021.116201_bb0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00223-021-00823-6","article-title":"Sclerostin directly stimulates osteocyte synthesis of fibroblast growth factor-23","volume":"109","author":"Ito","year":"2021","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2021.116201_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bone.2012.09.016","article-title":"Effects of PTH on osteocyte function","volume":"54","author":"Bellido","year":"2013","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2021.116201_bb0075","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1359\/jbmr.070507","article-title":"Age-related changes in trabecular architecture differ in female and male C57BL\/6J mice","volume":"22","author":"Glatt","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116201_bb0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.matbio.2015.12.009","article-title":"Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23","volume":"52\u201354","author":"Ren","year":"2016","journal-title":"Matrix Biol."},{"issue":"7","key":"10.1016\/j.bone.2021.116201_bb0085","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.116201_bb0090","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jbmr.2539","article-title":"Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones","volume":"30","author":"Jepsen","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116201_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.116201_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/00005792-198911000-00002","article-title":"X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults","volume":"68","author":"Reid","year":"1989","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.bone.2021.116201_bb0105","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J. Endocrine Soc."},{"issue":"21","key":"10.1016\/j.bone.2021.116201_bb0110","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2021.116201_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/8756-3282(95)00210-5","article-title":"Effect of abnormal mineralization on the mechanical behavior of x-linked hypophosphatemic mice femora","volume":"17","author":"Camacho","year":"1995","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2021.116201_bb0120","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jbmr.3038","article-title":"Sclerostin antibody administration converts bone lining cells into active osteoblasts","volume":"32","author":"Kim","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116201_bb0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bonekey.2013.231","article-title":"Phosphate metabolism and vitamin D","volume":"3","author":"Fukumoto","year":"2014","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.bone.2021.116201_bb0130","doi-asserted-by":"crossref","first-page":"496514","DOI":"10.1186\/1687-9856-2009-496514","article-title":"Fibroblast growth factor 23 (FGF23) and disorders of phosphate metabolism","volume":"2009","author":"Saito","year":"2009","journal-title":"Int. J. Pediatr. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2021.116201_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5049\/EBP.2008.6.2.77","article-title":"Kidney and phosphate metabolism","volume":"6","author":"Choi","year":"2008","journal-title":"Electrolyte Blood Press."},{"issue":"10","key":"10.1016\/j.bone.2021.116201_bb0140","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","article-title":"Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism","volume":"18","author":"Kawata","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.bone.2021.116201_bb0145","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.bone.2021.116201_bb0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo","volume":"49","author":"Rhee","year":"2011","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2021.116201_bb0155","doi-asserted-by":"crossref","first-page":"F1271","DOI":"10.1152\/ajprenal.00252.2003","article-title":"Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c","volume":"285","author":"Tenenhouse","year":"2003","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.bone.2021.116201_bb0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00424-008-0580-8","article-title":"Regulation of phosphate transport in proximal tubules","volume":"458","author":"Biber","year":"2009","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"issue":"1","key":"10.1016\/j.bone.2021.116201_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00008.2019","article-title":"Phosphate transport in epithelial and nonepithelial tissue","volume":"101","author":"Hernando","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bone.2021.116201_bb0170","series-title":"Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals","first-page":"437","article-title":"Chapter 36 - transcriptional regulation of sodium-phosphate cotransporter gene expression","author":"Kaneko","year":"2017"},{"issue":"16","key":"10.1016\/j.bone.2021.116201_bb0175","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bone.2021.116201_bb0180","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1210\/me.2009-0085","article-title":"Novel regulators of Fgf23 expression and mineralization in Hyp bone","volume":"23","author":"Liu","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2021.116201_bb0185","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI113172","article-title":"Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D","volume":"80","author":"Portale","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bone.2021.116201_bb0190","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1681\/ASN.2010080803","article-title":"The circadian clock in the kidney","volume":"22","author":"Stow","year":"2011","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:57:22Z","timestamp":1757613442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221003677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"alternative-id":["S8756328221003677"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116201","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116201"}}